InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,173.60
(
0.55%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.37%
)
Bitcoin
65,840.46
(
-1.37%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

furbush87

Send PM Follow Ignore
Followers 0
Posts 846
Boards Moderated 0
Alias Born 07/10/2014

furbush87

Re: LifterPuller post# 22509

Monday, 09/22/2014 3:13:55 PM

Monday, September 22, 2014 3:13:55 PM

Post# of 48316
I think the most comparable I have seen so far is ADXS. I have not done extensive research on them, but from the article today they are about 2x what ONCS is, with 2 drugs in P2, treating about 5-6 different cancers. I know you could argue ONCS has ImmunoPulse and NeoPulse, but its not an apples to apples comparison. They also have 2 partnerships, the deal with Merck is fairly inconsequential for the PD1 drug, and 3 orphan designations.
ADXS has a MC of $850m,
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM

Start posting your company's news
Only $200 per official company press release!